Effect of Electroacupuncture on P6 Acupoint on Hypertensive Patients. (EEP6)

August 12, 2020 updated by: Lin Ho Wong, Ong Fujian Chinese Physician Hall
This is a randomized controlled clinical trial with three parallel arms. This trial aims to evaluate the effectiveness of electroacupuncture on P6 acupoint for patients with hypertension,with respect to decreasing their blood pressure, safety of acupuncture ,and improving their quality of life as well.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

150

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Singapore
      • Singapore, Singapore, 427513
        • Ong Fujian Chinese Physician Hall
        • Contact:
          • Lin Ho Wong, MB BCh BAO
          • Phone Number: 82992667

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients above 18 years old
  • Have not recently had any changes in anti-hypertensive medications
  • Have not recently been discharged from hospital/are stable
  • Is not having any acute infection.

Exclusion Criteria:

  • Trypanophobia
  • Below 18 years of age
  • Is currently having an acute infection
  • Is unstable or have been discharged recently from hospital
  • Changes made to anti-hypertensive medications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Unilateral electroacupuncture of p6 acupoint
Procedure: Acupuncture
In each session, acupuncture are applied unilaterally or bilaterally on P6 acupoint. Each acupuncture needle will be stimulated by transcutaneous electric device.
Experimental: Bilateral electroacupuncture of p6 acupoint
Procedure: Acupuncture
In each session, acupuncture are applied unilaterally or bilaterally on P6 acupoint. Each acupuncture needle will be stimulated by transcutaneous electric device.
Sham Comparator: Sham acupuncture of p6 acupoint
Procedure: Sham acupuncture
Sham acupuncture

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reduction of blood pressure.
Time Frame: up to 6 months
It is expected that both blood pressure and heart rate will be reduced during the electroacupuncture of P6 acupoint.
up to 6 months
Reduction of Heart Rate
Time Frame: up to 6 months
Heart Rate is also expected to be reduced with the stimulation of p6 acupoint.
up to 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ong Fujian Chinese Physician Hall

Investigators

  • Study Director: Lin Ho Wong, MB BCH BAO, Ong Fujian Chinese Physician Hall
  • Principal Investigator: Pang Ong Wong, PhD, Ong Fujian Chinese Physician Hall
  • Study Chair: Eng Soon Ong, Bachelor of TCM, Ong Fujian Chinese Physician Hall
  • Study Chair: Choo Keok Lim, PhD, Ong Fujian Chinese Physician Hall

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

September 1, 2020

Primary Completion (Anticipated)

February 1, 2021

Study Completion (Anticipated)

April 30, 2021

Study Registration Dates

First Submitted

August 11, 2020

First Submitted That Met QC Criteria

August 12, 2020

First Posted (Actual)

August 14, 2020

Study Record Updates

Last Update Posted (Actual)

August 14, 2020

Last Update Submitted That Met QC Criteria

August 12, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • OngFujianCPH

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Sham acupuncture

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe